Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Fighting Lupus Among Latinas

From the College  |  October 18, 2018

Systemic lupus erythematosus (SLE) is more prevalent among Hispanic women than white women, according to two recent studies published in Arthritis & Rheumatology.1,2 However, Latinas often lack awareness of lupus, which can contribute to delays in diagnosis and treatment, and lead to worse outcomes. “One of the challenges is reaching out to the Latino community,…

Coding Corner Answer: Rheumatology Coding & Practice Quiz

From the College  |  October 18, 2018

Take the challenge. B or D—If it was not documented, it was not done is the motto of many coders. For those who follow this motto, the answer would be B. But there is another option for the coder and that is to query the physician about whether the injection was done with ultrasound guidance…

Coding Corner Question: Rheumatology Coding & Practice Quiz

From the College  |  October 18, 2018

1. A 45-year-old female patient with a diagnosis of primary osteoarthritis returns to the office for her second scheduled injection of sodium hyaluronate (Supartz). The nurse takes the patient’s vitals: weight is 185 lbs., height is 5’2”, and temperature is 98.2°F. The patient is prepped and given the injection. How should this encounter be coded?…

2018 Annual Meeting Attendees Receive Complimentary ACR Beyond Subscription

From the College  |  October 18, 2018

The ACR/ARHP is very pleased to announce that all scientific attendees at the 2018 ACR/ARHP Annual Meeting will receive a complimentary one-year subscription to ACR Beyond streaming (a $279 value). This complimentary subscription includes not only all of the recorded sessions from the 2018 ACR/ARHP Annual Meeting, but also more than 500 sessions from past…

A New Endowment Will Support Pediatric Rheumatology Fellowships

From the College  |  October 18, 2018

The Rheumatology Research Foundation has received a major donation from Audrey M. Nelson, MD, a retired rheumatologist from the Mayo Clinic in Rochester, Minn. The Audrey M. Nelson, MD, Pediatric Rheumatology Fellowship Endowment in Training will support training awards for pediatric rheumatology fellowships. This generous donation addresses the growing demand for pediatric rheumatologists to ensure…

Permanent Vision Loss in Late Giant Cell Arteritis

Kimberly Retzlaff  |  October 18, 2018

Patients with polymyalgia rheumatica (PMR) or peripheral arthritis may require extra vigilance during treatment because of a suspected link to giant cell arteritis (GCA) and, potentially, permanent vision loss. “Development of giant cell arteritis after treating polymyalgia or peripheral arthritis: a retrospective case-control study,” a March 2018 study published in The Journal of Rheumatology, suggests…

Study Sees Improvement in OA Patients Who Received Ayurvedic Therapy

Elizabeth Hofheinz, MPH, MEd  |  October 18, 2018

Mounting evidence suggests that humans have a complex and integrated mind-body system. Knee problems may affect the spine and other body parts, but also the mind—and vice versa. This is the wisdom of Ayurveda, the 3,000-year-old traditional medicine from India. A team of researchers from Germany recently undertook a study, titled “Effectiveness of an Ayurveda…

Rheumatology in China from Its Beginning to Today

Xiaofeng Zeng, MD, & Qingping Yao, MD, PhD  |  October 18, 2018

Rheumatology in China is a relatively young discipline, but it has developed exponentially over the past three decades. In this article, we review the history of rheumatology in China and advances in clinical care, research and education in this field. The Founding Father Naizheng Zhang, MD, is widely regarded as the father of rheumatology in…

Granulomatosis with Polyangiitis Rates & Outcomes

Ruth Jessen Hickman, MD  |  October 18, 2018

A recent study in Arthritis & Rheumatology highlights new information about the epidemiology and disease course of the vasculitic disease granulomatosis with polyangiitis (GPA, formerly known as Wegener’s disease).1 GPA is a rare disease that’s generally specific to the lungs, kidneys and the upper airways. The study provides key new data about the incidence and…

Study Suggests Tocilizumab Monotherapy May Work for Some RA Patients

Mary Beth Nierengarten  |  October 18, 2018

For patients with rheumatoid arthritis (RA) who respond to subcutaneous tocilizumab, discontinuing methotrexate may be an option and offer an alternative to patients who cannot tolerate or prefer not to take methotrexate. “This is one of the first studies showing that methotrexate may be discontinued in a cohort of patients with a biologic agent without…

  • « Previous Page
  • 1
  • …
  • 306
  • 307
  • 308
  • 309
  • 310
  • …
  • 816
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences